What is Alkermes's stock issuance proceeds?

Alkermes (ALKS) reported stock issuance proceeds of $15.71M in Q1 2026.

How has Alkermes's stock issuance proceeds changed year-over-year?

Alkermes's stock issuance proceeds decreased by 46.8% year-over-year, from $29.53M to $15.71M.

What is the long-term trend for Alkermes's stock issuance proceeds?

Over 4 years (2021 to 2025), Alkermes's stock issuance proceeds has grown at a 14.4% compound annual growth rate (CAGR), from $25.32M to $43.41M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Alkermes ALKS Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Jazz PharmaceuticalsJAZZ

$32.9M+186%

Axsome TherapeuticsAXSM

$6.34M-67.7%

Ionis PharmaceuticalsIONS

$57.3M+2,457%

Neurocrine BiosciencesNBIX

$23.6M-26.5%

Arrowhead ResearchARWR

$46.83M—

Rhythm Pharmaceuticals, Inc.RYTM

——

Other financials

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Free cash flow-$169.8M-291%

Valuation

See full

Market cap$7.5B+9.7%

Enterprise value$8.73B+41.2%

P/E49.1×+29.7×

P/S4.8×+0.3×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alkermes's stock issuance proceeds?: Alkermes (ALKS) reported stock issuance proceeds of $15.71M in Q1 2026.
How has Alkermes's stock issuance proceeds changed year-over-year?: Alkermes's stock issuance proceeds decreased by 46.8% year-over-year, from $29.53M to $15.71M.
What is the long-term trend for Alkermes's stock issuance proceeds?: Over 4 years (2021 to 2025), Alkermes's stock issuance proceeds has grown at a 14.4% compound annual growth rate (CAGR), from $25.32M to $43.41M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.